UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 26, 2024
Accession Number: 0001628280-24-017677
Submission Type: POS AM
CIK: 0001516551
Company Name: Skye Bioscience, Inc.
File Number: 333-278286